Marketing and business development executives from gene sequencing and synthesis technology companies Biotechnology and pharmaceutical companies that use gene sequencing and synthesis technologies Planning executives from energy, chemical, and vaccine industries interested in tracking how emerging technologies with disruptive and strategic importance will affect their industries in the years ahead Academic researchers and students active in the fields of gene sequencing, synthesis and synthetic biology Government policy makers, regulators and researchers from DOD, NSA, USDA, USDOE, FDA, EPA, Homeland Security and other federal agencies concerned with these emerging technologies